These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6337803)

  • 1. Netilmicin (Netromycin, Schering-Plough).
    Guay DR
    Drug Intell Clin Pharm; 1983 Feb; 17(2):83-91. PubMed ID: 6337803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Netilmicin sulfate: a comparative evaluation of antimicrobial activity, pharmacokinetics, adverse reactions and clinical efficacy.
    Craig WA; Gudmundsson S; Reich RM
    Pharmacotherapy; 1983; 3(6):305-15. PubMed ID: 6361701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
    Noone P
    Drugs; 1984 Jun; 27(6):548-78. PubMed ID: 6376062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
    Edson RS; Keys TF
    Mayo Clin Proc; 1983 Feb; 58(2):99-102. PubMed ID: 6823164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, and sisomicin.
    Edson RS; Terrell CL
    Mayo Clin Proc; 1987 Oct; 62(10):916-20. PubMed ID: 3657309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Netilmicin: clinical evaluation of efficacy and toxicity of a new aminoglycoside.
    Nordström L; Christensson P; Haeger K; Juhlin I; Tjernström O; Wallmark E
    J Int Med Res; 1979; 7(2):117-26. PubMed ID: 478159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Update on antibiotic therapy. 21) Netilmicin].
    Di Nola F
    Minerva Med; 1984 Feb; 75(5):211-8. PubMed ID: 6608068
    [No Abstract]   [Full Text] [Related]  

  • 9. Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Campoli-Richards DM; Chaplin S; Sayce RH; Goa KL
    Drugs; 1989 Nov; 38(5):703-56. PubMed ID: 2689137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Netilmicin: chemical development and overview of clinical research.
    Herting RL; Lane AZ; Lorber RR; Wright JJ
    Scand J Infect Dis Suppl; 1980; Suppl 23():20-9. PubMed ID: 7010547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae.
    Tselentis J; Legakis NJ; Nicolas KJ; Melissinos K; Papavassiliou J
    Chemotherapy; 1980; 26(6):409-17. PubMed ID: 7408554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR; Krafczyk TL
    Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative distribution of gentamicin, tobramycin, sisomicin, netilmicin, and amikacin in interstitial fluid in rabbits.
    Carbon C; Contrepois A; Lamotte-Barrillon S
    Antimicrob Agents Chemother; 1978 Mar; 13(3):368-72. PubMed ID: 263882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nephrotoxic potential of netilmicin as determined in a rat model.
    Luft FC
    Scand J Infect Dis Suppl; 1980; Suppl 23():82-90. PubMed ID: 6937971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of netilmicin therapy in serious infections.
    Jahre JA; Fu KP; Neu HC
    Am J Med; 1979 Jan; 66(1):67-73. PubMed ID: 420253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Netilmicin: in-vitro activity compared with that of other aminoglycosides against Serratia marcescens.
    Langstaff D; Schueler S; Righter J
    J Antimicrob Chemother; 1983 Feb; 11(2):187-9. PubMed ID: 6339461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Netilmicin in the treatment of severe or complicated urinary tract infections.
    Peddie BA; Bailey RR; Blake E; Summerfield MJ
    N Z Med J; 1980 May; 91(660):378-81. PubMed ID: 6931321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ototoxicity and nephrotoxicity of gentamicin vs netilmicin in patients with serious infections. A randomized clinical trial.
    Tange RA; Dreschler WA; Prins JM; Büller HR; Kuijper EJ; Speelman P
    Clin Otolaryngol Allied Sci; 1995 Apr; 20(2):118-23. PubMed ID: 7634515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I; Tunevall G
    Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.